These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 463346)

  • 1. Isoniazid acetylator phenotypes of Nigerians.
    Afonja AO; Arhavwarien ED; Okotore RO; Femi-Pearse D
    Niger Med J; 1979 Jan; 9(1):86-8. PubMed ID: 463346
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the isoniazid acetylator phenotype in a West African population.
    Salako LA; Aderounmu AF
    Tubercle; 1977 Jun; 58(2):109-12. PubMed ID: 878015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.
    Ellard GA
    Tubercle; 1984 Sep; 65(3):211-27. PubMed ID: 6385429
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid acetylator phenotyping of Amharas in Ethiopia.
    Russell SL; Russell DW
    Afr J Med Sci; 1973 Jan; 4(1):1-5. PubMed ID: 4695980
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.
    Gurumurthy P; Krishnamurthy MS; Nazareth O; Parthasarathy R; Sarma GR; Somasundaram PR; Tripathy SP; Ellard GA
    Am Rev Respir Dis; 1984 Jan; 129(1):58-61. PubMed ID: 6367570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Cas Lek Cesk; 1984 Feb; 123(6):158-64. PubMed ID: 6697364
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isoniazid acetylation among Brazilian Caucasoids and Negroids with pulmonary tuberculosis].
    Beiguelman B; Ramalho AS; Arena JF; Garlipp CR
    Rev Paul Med; 1977; 89(1-2):12-5. PubMed ID: 918481
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
    Mason E; Russell DW
    Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.
    Ellard GA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):610-25. PubMed ID: 773583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of the rapid isoniazid acetylator phenotype in Lagos (Nigeria).
    Odeigah PG; Okunowo MA
    Hum Hered; 1989; 39(1):26-31. PubMed ID: 2759621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified isoniazid acetylator phenotyping.
    Russell DW; Eidus L
    Can Med Assoc J; 1972 Jun; 106(11):1155-6. PubMed ID: 5034694
    [No Abstract]   [Full Text] [Related]  

  • 14. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology of isoniazid].
    Sokolova GV; Ivleva AIa; Ziia AV; Zeliger LR; Suvorova VI
    Probl Tuberk; 1984 Sep; (9):55-60. PubMed ID: 6504886
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype.
    Yamamoto T; Suou T; Hirayama C
    Hepatology; 1986; 6(2):295-8. PubMed ID: 3957235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.
    Sinha CP; Sinha S; Sinha KP
    J Assoc Physicians India; 1978 May; 26(5):353-60. PubMed ID: 730714
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid acetylator status of Black South African tuberculosis patients.
    Bach PH; Higgins-Opitz SB; Bima B; Leary WP
    S Afr Med J; 1976 Jul; 50(29):1132-4. PubMed ID: 959925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment.
    Alarcón-Segovia D; Fishbein E; Alcalá H
    Arthritis Rheum; 1971; 14(6):748-52. PubMed ID: 5316358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
    Powłowska I; Rakowska Z
    Pneumonol Pol; 1978 Aug; 46(8):605-12. PubMed ID: 714703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.